Susan Domchek
Susan Domchek
Verified email at - Homepage
Cited by
Cited by
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
M Robson, SA Im, E Senkus, B Xu, SM Domchek, N Masuda, S Delaloge, ...
New England Journal of Medicine 377 (6), 523-533, 2017
Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
A Tutt, M Robson, JE Garber, SM Domchek, MW Audeh, JN Weitzel, ...
The Lancet 376 (9737), 235-244, 2010
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
B Kaufman, R Shapira-Frommer, RK Schmutzler, MW Audeh, ...
Journal of clinical oncology 33 (3), 244-250, 2015
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers
TR Rebbeck, ND Kauff, SM Domchek
Journal of the National Cancer Institute 101 (2), 80-87, 2009
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
ANJ Tutt, JE Garber, B Kaufman, G Viale, D Fumagalli, P Rastogi, ...
New England Journal of Medicine 384 (25), 2394-2405, 2021
Breast-Cancer Risk in Families with Mutations in PALB2
AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ...
New England Journal of Medicine 371 (6), 497-506, 2014
Gene-panel sequencing and the prediction of breast-cancer risk
DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ...
New England Journal of Medicine 372 (23), 2243-2257, 2015
Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma
JC Bendell, SM Domchek, HJ Burstein, L Harris, J Younger, I Kuter, ...
Cancer 97 (12), 2972-2977, 2003
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study
ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ...
Journal of clinical oncology 26 (8), 1331-1337, 2008
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2 …
ME Robson, N Tung, P Conte, SA Im, E Senkus, B Xu, N Masuda, ...
Annals of Oncology 30 (4), 558-566, 2019
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology
MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ...
Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021
A population-based study of genes previously implicated in breast cancer
C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ...
New England Journal of Medicine 384 (5), 440-451, 2021
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility
ME Robson, AR Bradbury, B Arun, SM Domchek, JM Ford, HL Hampel, ...
Journal of Clinical Oncology 33 (31), 3660-3667, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Multidisciplinary meeting on male breast cancer: summary and research recommendations
LA Korde, JA Zujewski, L Kamin, S Giordano, S Domchek, WF Anderson, ...
Journal of clinical oncology 28 (12), 2114-2122, 2010
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility
ME Robson, CD Storm, J Weitzel, DS Wollins, K Offit
Journal of clinical oncology 28 (5), 893-901, 2010
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation …
TR Rebbeck, T Friebel, T Wagner, HT Lynch, JE Garber, MB Daly, ...
Journal of clinical oncology 23 (31), 7804-7810, 2005
The system can't perform the operation now. Try again later.
Articles 1–20